Your session is about to expire
← Back to Search
N/A
Omit breast radiation for Breast Cancer
Phase 2
Waitlist Available
Led By Armando Giuliano, MD, FACS, FRCSEd
Research Sponsored by Armando Giuliano
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at time of consent. assessed up to 3 years
Awards & highlights
Study Summary
This trial will test whether it's possible to skip radiation therapy after breast-conserving surgery for HER2-positive breast cancer, if the cancer appears to be completely gone after the surgery.
Eligible Conditions
- HER2-positive Breast Cancer
- Breast Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at time of consent. assessed up to 3 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at time of consent. assessed up to 3 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Feasibility of enrolling patients measured by proportion of recruited patients to participate in the trial
Trial Design
1Treatment groups
Experimental Treatment
Group I: Omit breast radiationExperimental Treatment1 Intervention
Find a Location
Who is running the clinical trial?
Armando GiulianoLead Sponsor
Armando Giuliano, MD, FACS, FRCSEdPrincipal InvestigatorCedars-Sinai Medical Center
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are currently breastfeeding.You are a woman.You have already received radiation therapy as part of your previous treatment.You have been diagnosed with inflammatory breast cancer.You have had breast cancer before, whether it was invasive or non-invasive.
Research Study Groups:
This trial has the following groups:- Group 1: Omit breast radiation
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any opportunities for enrollment in this clinical trial?
"According to information found on clinicaltrials.gov, this trial is no longer looking for individuals to participate in the study. Posted initially on May 1st 2022 and edited lastly on May 10th 2022, it has since concluded its recruitment process; however there are still 2610 other trials actively seeking eligible candidates right now."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger